<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>NMDA receptor antagonist &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/nmda-receptor-antagonist/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Oct 2026 17:52:48 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>NMDA receptor antagonist &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Ketamine Infusions Rise Sharply Among the Sickest Preterm Infants With Severe Lung Disease</title>
		<link>https://bioengineer.org/ketamine-infusions-rise-sharply-among-the-sickest-preterm-infants-with-severe-lung-disease/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 26 Oct 2026 17:52:48 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bronchopulmonary dysplasia]]></category>
		<category><![CDATA[ketamine]]></category>
		<category><![CDATA[necrotizing enterocolitis]]></category>
		<category><![CDATA[neonatal intensive care]]></category>
		<category><![CDATA[neurodevelopmental safety]]></category>
		<category><![CDATA[NMDA receptor antagonist]]></category>
		<category><![CDATA[preterm infants]]></category>
		<category><![CDATA[pulmonary hypertension]]></category>
		<category><![CDATA[retrospective cohort study]]></category>
		<category><![CDATA[sedation]]></category>
		<category><![CDATA[Temporal]]></category>
		<category><![CDATA[tracheostomy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=454949</guid>

					<description><![CDATA[A 15-year multicenter analysis of 8,888 extremely preterm infants with severe bronchopulmonary dysplasia found that continuous ketamine infusions, though rare, rose significantly after 2020 and were concentrated in infants with pulmonary hypertension, necrotizing enterocolitis, and tracheostomies.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">454949</post-id>	</item>
	</channel>
</rss>
